Boston: QMENTA – The innovative platform for clinical trials and research, providing an all-in-one platform that enables secure and compliant data aggregation and transfer in addition to AI-powered state-of-the-art algorithms for experts to be more efficient and fast in their day to day neuroimaging workflows – officially announces Dr Rosen’s arrival as scientific advisor.

Bruce Rosen will be part of the QMENTA adventure, providing his expertise of 35 years as both an academic investigator and a professor. With Dr. Rosen’s insight, QMENTA will continue to partner with essential stakeholders in neuroscience, especially to achieve its main goal: Helping to make brain diseases a thing of the past.

As QMENTA celebrates its 5-year anniversary, the addition of a new advisor enables Paulo Rodrigues – QMENTA’s CEO – to take a look back on what has been achieved:

“Through the years, we have been developing and improving our unique neuroimaging web-platform in order to help our clients save valuable resources and time on their R&D workflows, in both the academic and biopharmaceutical markets. To continue to provide the best solution to our customers, it is essential for us to have the guidance from prominent scientific experts such as Dr Rosen. His experienced insight in research and the imaging industry, is a great addition to our expanding board as we progress the technology and expand our market footprint”.

Bruce Rosen

Bruce Rosen MD, PhD is the Director of the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital, the Massachusetts Institute of Technology (MIT) and Harvard Medical School, as well as the Lawrence Lamson Robbins Professor of Radiology at the Harvard Medical School. He is responsible for the development of magnetic resonance (MR) imaging techniques internationally used by the neuroscience community. Moreover, he is one of the principal investigators involved in The Human Connectome project – aiming to use state-of-the-art neuroimaging technologies to visualize the brain and move forward in the discovery of treatments for neurological diseases.  In 35 years, he has become one of the most well-respected and followed figures in academic research of the brain.

Throughout his brilliant career, he also received awards such as the International Society of Magnetic Resonance in Medicine (ISMRM) gold medal in functional MR imaging in 1997. He was honored as a fellow of ISMRM in 1999 and of the American Institute for Biomedical Engineering in 2006. He was also elected to the National Academy of Medicine in 2013, is a Fellow of the American Academy of Arts and Sciences in 2016, and invited to join the National Academy of Inventors in 2017.

He is uniquely suited to advise on the development of new algorithms for the analysis of neuroimages and the advancement of the existing platform to respond to the needs of researchers and doctors around the world. Dr. Rosen commented: “QMENTA is focused on translating research into clinical care and improving patient outcomes with its products and expertise. The team designed a platform using the most advanced technologies to provide tools that can make a difference in experts’ day-to-day activities in neuroscience and neurology. They offer a compliant, reliable and efficient solution that enables clear and quantified results using various imaging markers, and deep learning techniques, suitable to use in both clinical trials and research space. The QMENTA platform will bring the neuroscience community together by enabling collaboration on data and algorithms in a reproducible and traceable way, which is one of the biggest challenges that this community is currently facing. QMENTA is the leader in translating state-of-the-art neuroimaging algorithms into clinical trials as well as clinical practice, and it’s a pleasure to serve in this advisory capacity.


QMENTA offers a cloud-based platform to streamline the medical imaging workflow for running clinical trials. QMENTA’s aim is to accelerate the discovery and development of new treatments for neurological diseases using state-of-the-art image processing techniques as well as deep learning techniques.

With headquarters in Boston and R&D in Barcelona, QMENTA has grown significantly since its creation in early 2013. Following its seed round of investment, the company has also increased its market reach in U.S. and E.U. through supporting many multi-center studies and a rapidly increasing the number of clinical trials.

Recently, QMENTA was awarded the “Best New Radiology Vendor” in 2017 from Aunt Minnie and was a European Winner for Accenture’s Healthtech Innovation Challenge. Most recently, QMENTA was featured in a Business Insider article as one the leading companies in Big Data.

Follow us on social media:

Twitter @QMENTA_Inc
Linkedin QMENTA Inc
Instagram QMENTA_Inc
Medium QMENTA Tech Blog